Françoise Descôtes

Author

Françoise Descôtes

Also Known As

Clémence Scard, Descotes, Françoise, Descôtes, Françoise, F Descotes, F. Descotes, FRANÇOISE DESCOTES, Francoise Descotes, Françoise DESCOTES, Françoise Descotes, Françoise Descôtes

118

Publications

1.7K

Citations

H-Index

Concepts

All Affiliations

Hôpital Lyon Sud Hospices Civils de Lyon Université Claude Bernard Lyon 1 Inserm Centre Léon Bérard

About

Françoise Descôtes is an author at Hôpital Lyon Sud specializing in medicine, pathology, and cancer research.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	15	16	667
2	Cell Biology	5	5	327
3	Health Sciences	2	2	57
4	Biostatistics	1	1	33
5	Immunology	1	1	65

Françoise Descôtes

Publications

1.4K

Citations

H-Index

Page 1

	Year	Citations
miRNA-30 Family Members Inhibit Breast Cancer Invasion, Osteomimicry, and Bone Destruction by Directly Targeting Multiple Bone Metastasis–Associated Genes Martine Croset, Francesco Pantano, Casina W.S. Kan, Cancer Research	2018	192
Cancer Cell Expression of Autotaxin Controls Bone Metastasis Formation in Mouse through Lysophosphatidic Acid-Dependent Activation of Osteoclasts Marion David, Estelle Wannecq, Françoise Descôtes, PLoS ONE	2010	115
Validation of tumor‐associated macrophage ferritin light chain as a prognostic biomarker in node‐negative breast cancer tumors: A multicentric 2004 national PHRC study Pascal Jézéquel, L. Campion, Frédérique Spyratos, International Journal of Cancer Multicentric 2004Breast OncologyNational Phrc StudyPathologyPrognostic Biomarker	2011	94
Non-invasive prediction of recurrence in bladder cancer by detecting somatic TERT promoter mutations in urine Françoise Descôtes, Norelyakin Kara, Myriam Decaussin‐Petrucci, British Journal of Cancer	2017	87
Dual Function of ERRα in Breast Cancer and Bone Metastasis Formation: Implication of VEGF and Osteoprotegerin Anaïs Fradet, Hélène Sorel, Lamia Bouazza, Cancer Research Bone Metastasis FormationTumor BiologyBreast OncologyCancer GrowthPathology	2011	81
Predictive factors of outcome in poorly differentiated thyroid carcinomas Christelle de la Fouchardière, Myriam Decaussin‐Petrucci, Julien Berthiller, European Journal of Cancer MedicinePredictive FactorsThyroid DiseaseThyroid HormoneOncology	2018	70
Targeting lysophosphatidic acid receptor type 1 with Debio 0719 inhibits spontaneous metastasis dissemination of breast cancer cells independently of cell proliferation and angiogenesis Marion David, Johnny Ribeiro, Françoise Descôtes, International Journal of Oncology Breast OncologyImmunologyLpa-dependent InvasionCancer BiologyTumor Biology	2011	65
Molecular testing of <i>BRAF, RAS</i> and <i>TERT</i> on thyroid FNAs with indeterminate cytology improves diagnostic accuracy Myriam Decaussin‐Petrucci, Françoise Descôtes, L. Depaepe, Cytopathology	2017	62
S-phase fraction and DNA ploidy in 633 T1T2 breast cancers: a standardized flow cytometric study. Agnès Chassevent, Marie‐Lise Jourdan, Sylvie Romain, PubMed Breast OncologyBreast Cancer ManagementPathologyCancer BiologyTumor Biology	2001	59
High expression of gabarapl1 is associated with a better outcome for patients with lymph node-positive breast cancer Alexandre Berthier, S. Seguin, Annie J. Sasco, British Journal of Cancer	2010	56

Page 1